Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 30

The DOI matches its Crossref record; the references it cites are not checked yet.

Influence of chain length on the anticancer activity of the antimicrobial peptide CAMEL with fatty acid modification

Ma, Ling, Huang, Sujie, Xie, Huan, Ma, Panpan, Jia, Bo, Yao, Yufan, Gao, Yuxuan, Li, Wenyuan, Song, Jingjing, Zhang, Wei · 2022 · European Journal of Medicinal Chemistry

Abstract

Antimicrobial peptides (AMPs) display promising potential in cancer therapy. Modification with fatty acids is a simple and effective approach to improve the activity of AMPs. In the present study, we investigated the effects of fatty acid chain lengths on the anticancer activity, self-assembly and mechanism of action of CAMEL (CM15, KWKLFKKIGAVLKVL-NH2), an amphipathic AMP with 15 amino acids. Conjugation of fatty acids could obviously improve the in vitro anticancer activity of CAMEL. Among the tested peptides, C12-CAMEL showed the highest anticancer activity, while C16-CAMEL killed cancer cells with the slowest kinetics. This may be related to the self-assembly of C12-CAMEL and C16-CAMEL, which could form spherical nanoparticles and tightened nanofibers, respectively. In addition, necrosis and necroptosis rather than apoptosis were the major mechanisms underlying the anticancer activity of CAMEL, C12-CAMEL and C16-CAMEL, implying that modification with fatty acids did not obviously alter the mechanism of action of CAMEL. Notably, C12-CAMEL, with high and rapid cell-killing activity, exhibited significantly stronger in vivo anticancer activity than CAMEL and C16-CAMEL. Overall, the present work suggests that the choice of a suitable fatty acid for structural modification is necessary for improving the anticancer activity of AMPs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejmech.2022.114557

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Cited by 30

Research works printed but not linked: 66

  1. Mookherjee, 2020, Antimicrobial host defence peptides: functions and clinical potential, Nat. Rev. Drug Discov., 19, 311, 10.1038/s41573-019-0058-8 · DOI · Paper page
  2. Chauhan, 2021, Antimicrobial peptides against colorectal cancer-a focused review, Pharmacol. Res., 167, 10.1016/j.phrs.2021.105529 · DOI
  3. Kunda, 2020, Antimicrobial peptides as novel therapeutics for non-small cell lung cancer, Drug Discov. Today, 25, 238, 10.1016/j.drudis.2019.11.012 · DOI
  4. Vitale, 2021, Targeting cancer heterogeneity with immune responses driven by oncolytic peptides, Trends in Cancer, 7, 557, 10.1016/j.trecan.2020.12.012 · DOI
  5. Gabernet, 2016, Membranolytic anticancer peptides, Medchemcomm, 7, 2232, 10.1039/C6MD00376A · DOI
  6. Hoskin, 2008, Studies on anticancer activities of antimicrobial peptides, Biochim. Biophys. Acta Biomembr., 1778, 357, 10.1016/j.bbamem.2007.11.008 · DOI · Paper page
  7. Rady, 2017, Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy, Cancer Lett., 402, 16, 10.1016/j.canlet.2017.05.010 · DOI · Paper page
  8. Zhang, 2019, Antimicrobial peptides: potential application in liver cancer, Front. Microbiol., 10
  9. Menacho-Melgar, 2019, A review of lipidation in the development of advanced protein and peptide therapeutics, J. Contr. Release, 295, 1, 10.1016/j.jconrel.2018.12.032 · DOI
  10. Zhang, 2012, Converting peptides into drug leads by lipidation, Curr. Med. Chem., 19, 1602, 10.2174/092986712799945003 · DOI · Paper page
  11. Zhang, 2019, Position effect of fatty acid modification on the cytotoxicity and antimetastasis potential of the cytotoxic peptide lycosin-I, J. Med. Chem., 62, 11108, 10.1021/acs.jmedchem.9b01126 · DOI
  12. Standley, 2010, Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide, Cancer Res., 70, 3020, 10.1158/0008-5472.CAN-09-3267 · DOI · Paper page
  13. Yang, 2020, Effect of hydrophobicity on the anticancer activity of fatty-acyl-conjugated CM4 in breast cancer cells, ACS Omega, 5, 21513, 10.1021/acsomega.0c02093 · doi:10.1021/acsomega.0c02093
  14. Andreu, 1992, Shortened cecropin-a melittin hybrids - significant size-reduction retains potent antibiotic-activity, FEBS Lett., 296, 190, 10.1016/0014-5793(92)80377-S · DOI · Paper page
  15. Choi, 2015, Single-cell, real-time detection of oxidative stress induced in Escherichia coli by the antimicrobial peptide CM15, Proc. Natl. Acad. Sci. U.S.A., 112, E303, 10.1073/pnas.1417703112 · DOI
  16. Smolarczyk, 2010, Anticancer effects of CAMEL peptide, Lab. Invest., 90, 940, 10.1038/labinvest.2010.58 · DOI
  17. Fantner, 2010, Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopy, Nat. Nanotechnol., 5, 280, 10.1038/nnano.2010.29 · DOI · Paper page
  18. Song, 2020, Acylation of the antimicrobial peptide CAMEL for cancer gene therapy, Drug Deliv., 27, 964, 10.1080/10717544.2020.1787556 · DOI
  19. Liu, 2016, Amphipathicity determines different cytotoxic mechanisms of lysine- or arginine-rich cationic hydrophobic peptides in cancer cells, J. Med. Chem., 59, 5238, 10.1021/acs.jmedchem.5b02016 · DOI
  20. Song, 2020, SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery, Drug Deliv., 27, 91, 10.1080/10717544.2019.1706669 · DOI
  21. Zager, 2013, Recent advances in the treatment of melanoma, Cancer Control, 20, 244, 10.1177/107327481302000401 · doi:10.1177/107327481302000401
  22. Rounds, 2020, Lipidation of antimicrobial peptides as a design strategy for future alternatives to antibiotics, Int. J. Mol. Sci., 21, 10.3390/ijms21249692 · DOI
  23. Zhong, 2021, Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance, Eur. J. Med. Chem., 212, 10.1016/j.ejmech.2020.113138 · DOI
  24. Chicharro, 2001, N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide, Antimicrob, Agents Chemother, 45, 2441, 10.1128/AAC.45.9.2441-2449.2001 · DOI
  25. Radzishevsky, 2005, Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides, Antimicrob. Agents Chemother., 49, 2412, 10.1128/AAC.49.6.2412-2420.2005 · DOI
  26. Tian, 2015, Role of peptide self-assembly in antimicrobial peptides, J. Pept. Sci., 21, 530, 10.1002/psc.2788 · DOI
  27. Chu-Kung, 2010, Chain length dependence of antimicrobial peptide-fatty acid conjugate activity, J. Colloid Interface Sci., 345, 160, 10.1016/j.jcis.2009.11.057 · DOI
  28. Haffner, 2018, Influence of self-assembly on the performance of antimicrobial peptides, Curr. Opin. Colloid Interface Sci., 38, 56, 10.1016/j.cocis.2018.09.002 · DOI
  29. Hendricks, 2017, Supramolecular assembly of peptide amphiphiles, Acc. Chem. Res., 50, 2440, 10.1021/acs.accounts.7b00297 · DOI · Paper page
  30. Javadpour, 1997, Self-assembly of designed antimicrobial peptides in solution and micelles, Biochemistry, 36, 9540, 10.1021/bi961644f · doi:10.1021/bi961644f
  31. Accardo, 2014, Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatment, Int. J. Nanomed., 9, 2137
  32. Schneider, 2010, Fluorescence spectroscopic determination of the critical aggregation concentration of the GnRH antagonists Cetrorelix, Teverelix and Ozarelix, J. Fluoresc., 20, 1233, 10.1007/s10895-010-0674-5 · doi:10.1007/s10895-010-0674-5
  33. Wan, 2016, Arginine-rich ionic complementary peptides as potential drug carriers: impact of peptide sequence on size, shape and cell specificity, Nanomed. Nanotechnol. Biol. Med., 12, 1479, 10.1016/j.nano.2016.01.008 · doi:10.1016/j.nano.2016.01.008
  34. Huang, 2010, Alpha-helical cationic antimicrobial peptides: relationships of structure and function, Protein Cell, 1, 143, 10.1007/s13238-010-0004-3 · DOI · Paper page
  35. Nguyen, 2011, The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol., 29, 464, 10.1016/j.tibtech.2011.05.001 · DOI · Paper page
  36. Liang, 2020, Role and modulation of the secondary structure of antimicrobial peptides to improve selectivity, Biomater. Sci., 8, 6858, 10.1039/D0BM00801J · DOI
  37. Hutchinson, 2017, Peptide hormones and lipopeptides: from self-assembly to therapeutic applications, J. Pept. Sci., 23, 82, 10.1002/psc.2954 · DOI
  38. Jian, 2018, The roles of fatty-acid modification in the activity of the anticancer peptide R-lycosin-I, Mol. Pharm., 15, 4612, 10.1021/acs.molpharmaceut.8b00605 · doi:10.1021/acs.molpharmaceut.8b00605
  39. Behzadi, 2020, Palmitoylation of membrane-penetrating magainin derivatives reinforces necroptosis in A549 cells dependent on peptide conformational propensities, ACS Appl. Mater. Interfaces, 12, 56815, 10.1021/acsami.0c17648 · DOI
  40. Liu, 2020, Modulation of antimicrobial peptide conformation and aggregation by terminal lipidation and surfactants, Langmuir, 36, 1737, 10.1021/acs.langmuir.9b03774 · DOI
  41. Avrahami, 2002, Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity, Biochemistry, 41, 2254, 10.1021/bi011549t · DOI · Paper page
  42. Xu, 2010, Self-assembly behavior of peptide amphiphiles (PAs) with different length of hydrophobic alkyl tails, Colloids Surf. B Biointerfaces, 81, 329, 10.1016/j.colsurfb.2010.07.027 · DOI
  43. de Almeida, 2019, Design, synthesis, and nanostructure-dependent antibacterial activity of cationic peptide amphiphiles, ACS Appl. Mater. Interfaces, 11, 2790, 10.1021/acsami.8b17808 · DOI
  44. Lombardi, 2019, Enhancing the potency of antimicrobial peptides through molecular engineering and self-assembly, Biomacromolecules, 20, 1362, 10.1021/acs.biomac.8b01740 · DOI
  45. Yang, 2021, Nanostructured antimicrobial peptides: crucial steps of overcoming the bottleneck for clinics, Front. Microbiol., 12
  46. Huang, 2015, Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs, Mini-Rev. Med. Chem., 15, 73, 10.2174/1389557514666141107120954 · doi:10.2174/1389557514666141107120954
  47. Farsinejad, 2015, Mitochondrial targeted peptides for cancer therapy, Tumour Biol, 36, 5715, 10.1007/s13277-015-3719-1 · DOI
  48. Lv, 2019, The antimicrobial peptide PFR induces necroptosis mediated by ER stress and elevated cytoplasmic calcium and mitochondrial ROS levels: cooperation with Ara-C to act against acute myeloid leukemia, Signal Transduct. Targeted Ther., 4
  49. Lee, 2015, Antimicrobial peptides (AMPs) with dual mechanisms: membrane: disruption and apoptosis, J. Microbiol. Biotechnol., 25, 759, 10.4014/jmb.1411.11058 · DOI
  50. Fulda, 2010, Targeting mitochondria for cancer therapy, Nat. Rev. Drug Discov., 9, 447, 10.1038/nrd3137 · DOI · Paper page
  51. Ellerby, 1999, Anti-cancer activity of targeted pro-apoptotic peptides, Nat. Med., 5, 1032, 10.1038/12469 · DOI · Paper page
  52. Law, 2006, A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity, Mol. Cancer Therapeut., 5, 1944, 10.1158/1535-7163.MCT-05-0509 · DOI
  53. Chen, 2001, RGD-tachyplesin inhibits tumor growth, Cancer Res., 61, 2434
  54. Bhola, 2016, Mitochondria-judges and executioners of cell death sentences, Mol. Cell., 61, 695, 10.1016/j.molcel.2016.02.019 · DOI · Paper page
  55. Han, 2011, Programmed necrosis: backup to and competitor with apoptosis in the immune system, Nat. Immunol., 12, 1143, 10.1038/ni.2159 · DOI · Paper page
  56. Tsujimoto, 1997, Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes, Cell Death Differ., 4, 429, 10.1038/sj.cdd.4400262 · DOI · Paper page
  57. Zhang, 2017, RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome, Nat. Commun., 8
  58. Zhu, 2013, Novel cytotoxic exhibition mode of antimicrobial peptide anoplin in MEL cells, the cell line of murine Friend leukemia virus-induced leukemic cells, J. Pept. Sci., 19, 566, 10.1002/psc.2533 · DOI
  59. Milhan, 2017, The antimicrobial peptide LL-37 as a possible adjunct for the proliferation and differentiation of dental pulp stem cells, J. Endod., 43, 2048, 10.1016/j.joen.2017.08.010 · DOI
  60. Paredes-Gamero, 2012, Characterization of dual effects induced by antimicrobial peptides: regulated cell death or membrane disruption, J. Pept. Sci., 18
  61. Ju, 2021, Antimicrobial peptide brevivin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells, Molecules, 26, 10.3390/molecules26072059 · DOI
  62. Darzynkiewicz, 1996, The cell cycle effects of camptothecin, Camptothecins, 803, 93
  63. Wang, 2016, Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis, Cancer Lett., 378, 1, 10.1016/j.canlet.2016.05.001 · DOI
  64. Babcook, 2014, Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells, Cell Death Dis., 5, e1536, 10.1038/cddis.2014.500 · DOI
  65. Hu, 2018, Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1, Apoptosis, 23, 132, 10.1007/s10495-018-1443-1 · doi:10.1007/s10495-018-1443-1
  66. Diaz-Moralli, 2013, Targeting cell cycle regulation in cancer therapy, Pharmacol. Ther., 138, 255, 10.1016/j.pharmthera.2013.01.011 · DOI · Paper page

Metadata

Authors
Ma, L., Huang, S., Xie, H., Ma, P., Jia, B., Yao, Y., Gao, Y., Li, W., Song, J., & Zhang, W.
Venue
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Published
2022-09
Volume
239
Pages
114557
ISSN
0223-5234
Cited by
30
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of chain length on the anticancer activity of the antimicrobial peptide CAMEL with fatty acid modification. https://app.cochat.ai/papers/10.1016/j.ejmech.2022.114557
The paper
Ma, L., Huang, S., Xie, H., Ma, P., Jia, B., Yao, Y., Gao, Y., Li, W., Song, J., & Zhang, W. (2022). Influence of chain length on the anticancer activity of the antimicrobial peptide CAMEL with fatty acid modification. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2022.114557

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.